Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study

BACKGROUND: The optimal treatment strategy with disease-modifying therapies (DMTs) in relapsing–remitting multiple sclerosis (RRMS) remains uncertain. OBJECTIVE: To compare outcomes of initial treatment with infusion therapies and starting therapy with medium efficacy therapy in a propensity-matched...

Descripción completa

Detalles Bibliográficos
Autores principales: Hänninen, K., Viitala, M., Atula, S., Laakso, S. M., Kuusisto, H., Soilu-Hänninen, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782786/
https://www.ncbi.nlm.nih.gov/pubmed/34170403
http://dx.doi.org/10.1007/s00415-021-10673-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782786/
https://www.ncbi.nlm.nih.gov/pubmed/34170403
http://dx.doi.org/10.1007/s00415-021-10673-9

Ejemplares similares